Biotechnology company Gilead Sciences Inc. says it will buy CV Therapeutics for about $1.4 billion as a wave of consolidation in the drug industry continues.

Mexican cement maker Cemex SAB de CV says it may sell 16 concrete-pipe manufacturing facilities in Australia to reduce its debt.

This guy is a newly become web team manager at Seattle Children Hospital. Since he says hospital, I would consider he and his team is not responsible for bringing...